Canaccord Genuity Reiterates a 'Buy' on Integrated Device Technology (IDTI); Headwind Lifted
Tweet Send to a FriendGet Alerts IDTI Hot Sheet
Price: $8.07 -0.25%
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade IDTI Now!
Canaccord Genuity reiterates a 'Buy' on Integrated Device Technology (NASDAQ: IDTI) price target of $9.00.
Analyst, Bobby Burleson, said, "We are reiterating our rating following IDTI’s release of an 8-K Wednesday detailing the agreement reached with Starboard, lifting a key headwind to the PLX Technology (Nasdaq: PLXT) acquisition. As a part of the agreement IDTI will expand its board to nine members, including two Starboard nominees, as well as set operating margin targets for F2013 and F2014 irrespective of the PLXT acquisition closing. While HSR antitrust approval remains, we believe approval is likely and we expect the deal will close in July."
"We are modeling operating margins of 11% for F2013, 15% for F2014, and exiting F2014 at 15%. We expect IDTI to achieve these operating margin targets with or without the PLXT acquisition."
For an analyst ratings summary and ratings history on Integrated Device Technology click here. For more ratings news on Integrated Device Technology click here.
Shares of Integrated Device Technology closed at $5.58 yesterday, with a 52 week range of $4.70-$8.10.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Bobby Burleson, said, "We are reiterating our rating following IDTI’s release of an 8-K Wednesday detailing the agreement reached with Starboard, lifting a key headwind to the PLX Technology (Nasdaq: PLXT) acquisition. As a part of the agreement IDTI will expand its board to nine members, including two Starboard nominees, as well as set operating margin targets for F2013 and F2014 irrespective of the PLXT acquisition closing. While HSR antitrust approval remains, we believe approval is likely and we expect the deal will close in July."
"We are modeling operating margins of 11% for F2013, 15% for F2014, and exiting F2014 at 15%. We expect IDTI to achieve these operating margin targets with or without the PLXT acquisition."
For an analyst ratings summary and ratings history on Integrated Device Technology click here. For more ratings news on Integrated Device Technology click here.
Shares of Integrated Device Technology closed at $5.58 yesterday, with a 52 week range of $4.70-$8.10.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Bausch & Lomb near deal to sell to Valeant Pharmaceuticals (VRX) - WSJ
- UPDATE: A.G. Lafley Gives Procter & Gamble (PG) Investors 'New Hope', UBS Upgrades to Buy
- Valeant (VRX) Continues Deal Hunt; Close to Buying Bausch & Lomb for $9B
Create E-mail Alert Related Categories
Analyst Comments, Mergers and AcquisitionsRelated Entities
Canaccord GenuityLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

